This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) slid 4.89% to $1.75 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 1.69% to 23,195.17 and Dow Jones Industrial Average  falling 0.51% to 48,458.05.
This was the stock's second consecutive day of losses.
TherapeuticsMD Inc. closed 28.28% short of its 52-week high of $2.44, which the company achieved on January 3rd.
The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. (ABBV) fell 0.29% to $223.32.
Trading volume (39,998) remained 243,639 below its 50-day average volume of 283,637.
Data source: Dow Jones Market Data, FactSet. Data compiled December 12, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-12-25 1732ET

ABBV

TXMD

<p>TherapeuticsMD Inc. (TXMD) shares fell 4.89% to $1.75 on Friday, underperforming compared to competitors like AbbVie Inc. (ABBV), which fell 0.29%. This marks the second consecutive day of losses for TXMD, closing 28.28% below its 52-week high. The trading volume was significantly below its 50-day average. The NASDAQ Composite and Dow Jones also saw declines.</p>

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors